Cargando…

Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)

PURPOSE: To investigate the safety and efficacy of micropulse (MP) macular laser in combination with intravitreal aflibercept for the treatment of center-involved diabetic macular edema (CI-DME). METHODS: A single-blind prospective randomized controlled pilot trial was performed. In total, 30 eyes o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koushan, Keyvan, Eshtiaghi, Arshia, Fung, Pauline, Berger, Alan R, Chow, David R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005121/ https://www.ncbi.nlm.nih.gov/pubmed/35422607 http://dx.doi.org/10.2147/OPTH.S360869

Ejemplares similares

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

Commentary: Subthreshold micropulse yellow laser in diabetic macular edema
por: Bansal, Mayank
Publicado: (2020)

Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review
por: Sabal, Barbara, et al.
Publicado: (2022)

Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema
por: Frizziero, Luisa, et al.
Publicado: (2021)

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020)

Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema
por: Akhlaghi, Mohammadreza, et al.
Publicado: (2018)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema
por: Dugel, Pravin U., et al.
Publicado: (2021)

Comparison of short-pulse subthreshold (532 nm) and infrared micropulse (810 nm) macular laser for diabetic macular edema
por: Al-Barki, Abdulrahman, et al.
Publicado: (2021)

The Short-term Efficacy of Subthreshold Micropulse Yellow (577-nm) Laser Photocoagulation for Diabetic Macular Edema
por: Kwon, Yoon Hyung, et al.
Publicado: (2014)

Aqueous humour concentrations of PEDF and Erythropoietin are not influenced by subthreshold micropulse laser treatment of diabetic macular edema
por: Midena, Edoardo, et al.
Publicado: (2019)

Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
por: Vujosevic, Stela, et al.
Publicado: (2020)

The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015)

The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
por: Herbaut, Antoine, et al.
Publicado: (2017)

Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review
por: Luttrull, Jeffrey K, et al.
Publicado: (2012)

Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edema
por: Othman, Ihab Saad, et al.
Publicado: (2014)

Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema
por: Midena, Edoardo, et al.
Publicado: (2019)

Short-term Efficacy of Micropulse Yellow Laser in Non-center-involving Diabetic Macular Edema: Preliminary Results
por: Değirmenci, Mehmet Fatih Kağan, et al.
Publicado: (2018)

Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema
por: Elhamid, Ahmed Hosni Abd
Publicado: (2017)

Anatomical and functional outcomes of subthreshold micropulse laser versus intravitreal ranibizumab injection in treatment of diabetic macular edema
por: Abdelrahman, Amr, et al.
Publicado: (2020)

Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments
por: Sun, Jennifer K., et al.
Publicado: (2021)

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema
por: Fazel, Farhad, et al.
Publicado: (2016)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
por: Mira, Filipe, et al.
Publicado: (2017)

The Role of Subthreshold Micropulse Yellow Laser as an Alternative Option for the Treatment of Refractory Postoperative Cystoid Macular Edema
por: Verdina, Tommaso, et al.
Publicado: (2020)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
por: Klein, Kendra A., et al.
Publicado: (2017)

Updates on the Clinical Trials in Diabetic Macular Edema
por: Demirel, Sibel, et al.
Publicado: (2016)

Coats' Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation
por: Shieh, Wen-Shi, et al.
Publicado: (2017)

Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study
por: Bonfiglio, Vincenza, et al.
Publicado: (2022)

Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study
por: Frizziero, Luisa, et al.
Publicado: (2021)

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial
por: Mi, Xuejing, et al.
Publicado: (2022)

Bradykinin 1 Receptor Antagonist BI1026706 Does Not Reduce Central Retinal Thickness in Center-Involved Diabetic Macular Edema
por: Lang, Gabriele E., et al.
Publicado: (2020)

Subthreshold Diode Micropulse Laser Combined with Intravitreal Therapy for Macular Edema—A Systematized Review and Critical Approach
por: Gawęcki, Maciej
Publicado: (2021)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim, Laurence S, et al.
Publicado: (2015)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
por: Ohara, Hiromi, et al.
Publicado: (2023)

Micropulse laser in patients with refractory and treatment-naïve center–involved diabetic macular edema: short terms visual and anatomic outcomes
por: Valera-Cornejo, Diego Alejandro, et al.
Publicado: (2021)

Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up
por: El Matri, Leila, et al.
Publicado: (2021)

A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders
por: Scholz, Paula, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dohfia3li9poauhjd03qm6akd7